Complications of Microvascular Decompression in patients with Trigeminal Neuralgia

Authors

  • Amjad Qaisarani Department of Neurosurgery, Punjab Institute of Neuroscience (PINS), Lahore – Pakistan
  • Rizwan AhmedK han
  • Irfan Sheikh Department of Neurosurgery, Punjab Institute of Neuroscience (PINS), Lahore – Pakistan
  • Madiha Fayyaz Lahore General Hospital

DOI:

https://doi.org/10.36552/pjns.v26i2.634

Keywords:

Microvascular Decompression

Abstract

Objective:  To determine the frequency of complications of microvascular decompression for patients with trigeminal neuralgia undergoing surgical decompression.

Materials and Methods:  A descriptive case study was carried out in the Neurosurgery Unit 1, Lahore General Hospital. The study included 80 patients who fulfilled the inclusion criteria. Informed consent was obtained and possible outcomes and complications of surgery were explained beforehand to the patients. Demographic details were noted. Surgical site infection, CSF leak, Facial numbness, Facial palsy, Hearing impairment, and Postoperative hematoma as complications were assessed. The presence of complications was recorded. Data was stratified for age and gender from. Chi-square was used as a statistical test, taking a p-value ?0.05 as the level of significance.

Results:  The study included 80 patients. The mean age of the patients was 40.8 ± 11.7 years. Overall complications were reported in 21 (26.3%) patients. Distribution of complications was as follows; surgical site infection 2 (9.5%), CSF leak (19.0%), facial palsy 5 (23.8%), facial numbness 9 (42.9%), hearing impairment 2 (9.5%) and post-operative hematoma 5 (23.8%).

Conclusion:  Microvascular decompression (MVD) is recommended neurosurgical procedure for medically refractory patients with trigeminal pain if there is no contraindication for surgery. Surgical complications can be minimized by meticulous surgery resulting in adequate tissue respect. Another means to get better and long-lasting results with fewer complications is by using an autologous muscle graft.

References

Montano N. Advances in diagnosis and treatment of trigeminal neuralgia. TherClin Risk Manag. 2015;11:289–99.

BK, Cockerell OC, Sander JW, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000; 123 ( Pt 4):665.

Childs AM, Meaney JF, Ferrie CD, Holland PC. Neurovascular compression of the trigeminal and glossopharyngeal nerve: three case reports. Arch Dis Child 2000; 82:311.

Katusic S, Beard CM, Bergstralh E, Kurland LT. Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984. Ann Neurol 1990; 27:89.

Ariai MS, Outcomes after microvascular decompression for patients with trigeminal neuralgia and suspected multiple sclerosis. World Neurosurg. 2014;81(3-4):599-603.

Toda H. Patterns and Variations in Microvascular Decompression for Trigeminal Neuralgia Neurol Med Chir (Tokyo). 2015;55(5):432–41.

Zakrzewska JM, Linskey ME. Trigeminal neuralgia. BMJ 2014; 348:g474.

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38:1.

Pareja JA, Barón M, Gili P. Objective assessment of autonomic signs during triggered first division trigeminal neuralgia. Cephalalgia 2002; 22:251.

Gronseth G, Cruccu G, Alksne J. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology 2008; 71:1183.

McCleane GJ. Intravenous infusion of phenytoin relieves neuropathic pain: a randomized, double-blinded, placebo-controlled, crossover study. AnesthAnalg 1999; 89:985.

Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbazepine (tegretol) in trigeminal neuralgia. J NeurolNeurosurg Psychiatry 1966; 29:265.

Jannetta PJ. Microsurgical management of trigeminal neuralgia. Arch Neurol 1985; 42:800.

Gronseth G, Cruccu G, Alksne J. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology 2008; 71:1183.

Sarsam Z, Garcia-Fiñana M, Nurmikko TJ, Varma TR, Eldridge P. The longterm outcome of microvascular decompression for trigeminal neuralgia. Br J Neurosurg. 2010;24(1):18-25.

Bohman LE, Pierce J, Stephen JH, Sandhu S, Lee JY. Fully endoscopic microvascular decompression for trigeminal neuralgia: technique review and early outcomes. Neurosurg Focus. 2014;37(4):18.

Hamlyn PJ, King TT. Neurovascular compression in trigeminal neuralgia: a clinical and anatomical study. J Neurosurg. 1992;76(6):948–954.

Burchiel KJ. Abnormal impulse generation in focally demyelinated trigeminal roots. J Neurosurg. 1980;53(5):674–83.

Slavin KV. Glossopharyngeal neuralgia. SeminNeurosurg. 2004;15:71–9.

Taylor JC, Brauer S, Espir MLE. Long-term treatment of trigeminal neuralgia with carbamazepine. Postgrad Med J. 1981;57(663):16–18.

Rushton JG, Olafson RA. Trigeminal neuralgia associated with multiple sclerosis. A case report. Arch Neurol. 1965;13(4):383–6.

Zhao H, Zhang X, Tang YD, Zhang Y. Operative Complications of Microvascular Decompression for Hemifacial Spasm: Experience of 1548 Cases World Neurosurg. 2017;107:559-64.

Xia L, Zhong J, Zhu J, Wang YN. Effectiveness and safety of microvascular decompression surgery for treatment of trigeminal neuralgia: a systematic review J Craniofac Surg. 2014;25(4):1413-7.

Bakker NA, Van Dijk JM, Immenga S, Wagemakers M, Metzemaekers JD. Repeat microvascular decompression for recurrent idiopathic trigeminal neuralgia. J Neurosurg. 2014;121(4):936-9.

Downloads

Published

2022-07-17